23 May 2013
Keywords: aerogen, initiates, ph, ii, trial, amikacin, initiated
Article | 10 January 2005
Aerogen has initiated a Phase II trial of amikacin, an aerosolized antibiotic, which aims to further investigate the drug's potential
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com